Safety and Efficacy Study of ENB-0040 in Juvenile Patients With Hypophosphatasia (HPP)

NCT00894075 · clinicaltrials.gov ↗
PHASE2
Phase
WITHDRAWN
Status
INDUSTRY
Sponsor class

Stopped Withdrawn pending further review of clinical design.

Conditions

Interventions

Sponsor

Alexion Pharmaceuticals, Inc.